Live from the NIH registry
Studies recruiting near Lancaster right now
Top 25 of 100 recruiting studies, sorted by proximity — each links to its official registry page
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 2
Interventional 270 participants sought
First Valley Medical Group — Lancaster, California (2.2 mi)
· Sponsor: Novo Nordisk A/S
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 140 participants sought
Om Research, LLC — Lancaster, California (2.2 mi)
· Sponsor: Eli Lilly and Company
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Intracerebral Hemorrhage, Stroke
N/A
Observational 1,018 participants sought
Antelope Valley Medical Center — Lancaster, California (2.2 mi)
· Sponsor: Zeenat Qureshi Stroke Institute
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 425 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Hoffmann-La Roche
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Brain Metastases
Phase 3
Interventional 206 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: Canadian Cancer Trials Group
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: NRG Oncology
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Alopecia Areata
Phase 2
Interventional 60 participants sought
Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway — Santa Clarita, California (29.5 mi)
· Sponsor: Eli Lilly and Company
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Crohn's Disease
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400001 — Lancaster, California (2.2 mi)
· Sponsor: Sanofi
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: Canadian Cancer Trials Group
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Focal Seizure, Epilepsy
Phase 3
Interventional 333 participants sought
Amicis Research Center — Palmdale, California (8.6 mi)
· Sponsor: Rapport Therapeutics Inc.
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
USC Norris Santa Clarita Oncology — Santa Clarita, California (29.5 mi)
· Sponsor: NRG Oncology
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Lancaster, California (2.2 mi)
· Sponsor: Akero Therapeutics, Inc
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
Chemidox Clinical Trials- Site Number : 8400075 — Lancaster, California (2.2 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Chronic Migraine
Phase 3
Interventional 780 participants sought
Chemidox Clinical Trials Inc, Merz Investigational Site #0010488 — Lancaster, California (2.2 mi)
· Sponsor: Merz Therapeutics GmbH
Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference
Colonic Polyps
N/A
Interventional 330 participants sought
Gastro Care Institute — Lancaster, California (2.2 mi)
· Sponsor: Capso Vision, Inc.
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 1,000 participants sought
Local Institution - 1142 — Lancaster, California (2.2 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Irritable Bowel Syndrome, Constipation
Phase 2
Interventional 342 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Eli Lilly and Company
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Ardelyx
Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers
Metastatic Pancreatic Adenocarcinoma
N/A
Interventional 136 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: City of Hope Medical Center
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 2
Interventional 224 participants sought
Gastro Care Institute — Lancaster, California (2.2 mi)
· Sponsor: Genentech, Inc.
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Overweight
Phase 3
Interventional 400 participants sought
First Valley Medical Group — Lancaster, California (2.2 mi)
· Sponsor: Novo Nordisk A/S
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8
Phase 2
Interventional 111 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: National Cancer Institute (NCI)